Please login to the form below
Medicare
This page shows the latest Medicare news and features for those working in and with pharma, biotech and healthcare.
Biogen’s Alzheimer’s treatment Aduhelm limited to clinical trial participants in the US
For Aduhelm and similar therapies, the policy will set national guidance on how Medicare treats these particular drugs in the future. ... The officials also added that trials must be demographically representative of Medicare patients suffering with
Latest news
-
Democrats in the US agree plan to curb drug prices
If the plan is approved by Congress, negotiations on the most expensive treatments covered by Medicare – for cancer and rheumatoid arthritis, for example – would start in 2023. ... Medicare is the federal healthcare programme that covers all people
-
Embattled Biogen talks up Aduhelm
The company even requested a narrowing of the indication to reduce the impact on payers' budgets, after estimates placed the bill for Medicare at $29bn for a single year. ... However, the Centers for Medicare and Medicaid Services (CMS) is not expected
-
US demand for COVID-19 antibody treatments rising fast
GSK has a co-pay programme for commercial patients and, due to previous government relief bills, patients with Medicare and Medicaid, and the uninsured, don’t have to pay to get
-
Pfizer, Sanofi and others set to increase US drug prices in 2021
One key tenet of Biden’s drug pricing pledge is to allow Medicare to negotiate drug prices directly with pharma companies.
-
Lilly joins new Medicare scheme to reduce insulin prices
The drugmaker will partake in the new ‘Senior Savings Model’, which aims to improve the affordability of insulin for seniors enrolled in Medicare Part D. ... insulins. According to Lilly, of the proportion of people paying over $100 per prescription
More from news
Approximately 6 fully matching, plus 159 partially matching documents found.
Latest Intelligence
-
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Between 2012 and 2016, annual spending on biologic drugs in the US nearly doubled, with unit prices accounting for 56% of the spending increase within Medicare Part D and 20% in ... In Medicare Part B, legislation could be passed to encourage physician
-
Eliminating pharmaceutical rebates, is this déjà vu?
Due to consolidation in the industry, most prescription drug benefits, including Medicare Part D benefits, are administered by several significant PBMs. ... Completely eliminating Medicare Part D rebates within PBMs is not essential for lowering the
-
The global antibiotic crisis: a 2020 perspective
2020. It seeks to incentivise drug developers by changing the way Medicare reimburses hospitals for treating patients with bacterial infections.
-
Will biosimilars ever catch on in the US?
Others call for more involvement from equally relevant and powerful government bodies, such as Congress, the Centers for Medicare and Medicaid Services, the US Patent and Trademark Office and the US
-
The Golden Goose
Yet another market-friendly idea that enjoys broad support among patient advocacy groups is allowing Medicare to negotiate with drugmakers. ... Unfortunately, on closer inspection, this pathway also presents difficulties. To negotiate effectively,
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
PhRMA appoints senior government affairs position
During this time, he worked on Medicare and issues related to the FDA.
-
Former FDA head to join J&J
He has additional senior experience in government, serving as the administrator of the Centers for Medicare &Medicaid Services for the US Department of Health and Human Services from 2004 to 2006.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Robust Review: Pricing & Market Access
To better assess the acceptability of their product, they leveraged Rapid Payer Response (RPR) to elicit insights from both the Medicare and the Commercial perspective by engaging with a large sample
-
How do ethnic minority groups in the U.S. view clinical trials?
They will be on state healthcare such as Medicare. They need education more.
-
Patients are ready to embrace decentralised clinical trials, are you?
investigational site.” Plus, the Centres for Medicare and Medicaid Services relaxed its reimbursement rates for telemedicine visits.
-
More tell, less sell: HCP-centric comms
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA.
-
Genetic counsellors: the new healthcare influencers?
In April 2018, Medicare &Medicaid Services announced patients with advanced cancer will have free access to genetic testing.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Moderna to launch Innovation and Technology Center in the UK
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
- VMLY&R wins two Grand Prix awards at Cannes Lions International Festival of Creativity 2022
- How digital health is changing the relationship between patients and health providers | OPEN Health
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Roche shares new positive Ocrevus data for MS patients
- Six UK universities receive grant for research into motor neurone disease
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
